Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 May 23;12(5):e0177293.
doi: 10.1371/journal.pone.0177293. eCollection 2017.

Oligopeptides as full-length New Delhi metallo-β-lactamase-1 (NDM-1) inhibitors

Affiliations

Oligopeptides as full-length New Delhi metallo-β-lactamase-1 (NDM-1) inhibitors

Bingzheng Shen et al. PLoS One. .

Abstract

'Superbug' bacteria producing NDM-1 enzyme causing wide public concern were first detected in a patient who visited India in 2008. It's an effective approach to combining β-lactam antibiotics with NDM-1 inhibitor for treating NDM-1 producing strain infection. In our research, we designed ten oligopeptides, tested IC50 values against NDM-1 enzyme, determined the MIC values of synergistic antibacterial effect and explored the binding model. We found that the oligopeptides 2 (Cys-Phe) and 5 (Cys-Asp) respectively presented IC50 values of 113 μM and 68 μM and also displayed favorable synergistic effects of the inhibitors in combination with ertapenem against genetic engineering-host E. coli BL21 (DE3)/pET30a-NDM-1 and a clinical isolate of P. aeruginosa with blaNDM-1. Flexible docking and partial charge study suggested the interaction between oligopeptide and NDM-1. Three types of action effects, hydrogen bond, electrostatic effect and π-π interaction, contributed to the inhibitory activities.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. Molecular structure of all oligopeptides against NDM-1.
Fig 2
Fig 2. Binding model between inhibitor and target of NDM-1 enzyme.
Binding models of the docked NDM-1 with oligopeptides 2 (Fig 2A) and 5 (Fig 2B), respectively. Structures of inhibitors were shown in stick model. NDM-1 was shown as ribbon model. Six key amino acids binding two zinc ions are colored by pink.
Fig 3
Fig 3. The best pose of inhibitor docked into the active site of NDM-1.
Oligopeptides 2 (Fig 3A) and 5 (Fig 3B) are shown as stick model. Water-bridge and two zinc ions are shown as sphere model (red and black, respectively). Seven key amino acids in catalytic center of NDM-1 (His189, His120, His122, Asp124, Cys208, His250 and Tyr229) treated as flexible residues are shown as line model.
Fig 4
Fig 4. The partial charge values of water-bridge, two zinc ions, and critical atoms of inhibitors.
Oligopeptides 2 (Fig 4A) and 5 (Fig 4B) are shown as stick model, which sulfur atom and oxygen atom are colored by yellow and red, respectively. Water-bridge and two zinc ions are shown as sphere model (red and black, respectively).

Similar articles

Cited by

References

    1. Gupta K, Martinello RA, Young M, Strymish J, Cho K, Lawler E. MRSA nasal carriage patterns and the subsequent risk of conversion between patterns, infection, and death. PLoS One. 2013; 8: e53674 10.1371/journal.pone.0053674 - DOI - PMC - PubMed
    1. Ahmed-Bentley J, Chandran AU, Joffe AM, French D, Peirano G, Pitout JD. Gram-negative bacteria that produce carbapenemases causing death attributed to recent foreign hospitalization. Antimicrob Agents Chemother. 2013; 57: 3085–91. 10.1128/AAC.00297-13 - DOI - PMC - PubMed
    1. Hoesly FJ, Baker SG, Gunawardane ND, Cotliar JA. Capecitabine-induced hand-foot syndrome complicated by pseudomonal superinfection resulting in bacterial sepsis and death: case report and review of the literature. Arch Dermatol. 2011; 147: 1418–23. 10.1001/archdermatol.2011.320 - DOI - PubMed
    1. Giedraitienė A, Vitkauskienė A, Naginienė R, Pavilonis A. Antibiotic resistance mechanisms of clinically important bacteria. Medicina (Kaunas). 2011; 47: 137–146. - PubMed
    1. Wickens H, Wade P. Understanding antibiotic resistance. Pharmaceutical journal 2005; 274: 501–504.

MeSH terms